Alliancebernstein L.P. Guardant Health, Inc. Transaction History

Alliancebernstein L.P.

$290 Billion
Q2 2025

A detailed history of Alliancebernstein L.P. transactions in Guardant Health, Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 140,308 shares of GH stock, worth $13.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

140,308

Previous 139,920 0.28%

Holding current value

$13.1 Million

Previous $5.96 Million 22.5%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$37.05 - $52.04 $14,375 - $20,191	388 Added 0.28%	140,308 $7.3 Million
Q1 2025 May 15, 2025	BUY	$31.77 - $49.94 $451,134 - $709,148	14,200 Added 11.29%	139,920 $5.96 Million
Q4 2024 Feb 12, 2025	SELL	$20.2 - $38.11 $363,600 - $685,980	-18,000 Reduced 12.52%	125,720 $3.84 Million
Q2 2024 Aug 14, 2024	BUY	$16.07 - $31.84 $198,657 - $393,606	12,362 Added 9.41%	143,720 $4.15 Million
Q1 2024 May 14, 2024	SELL	$17.13 - $26.91 $61.3 Million - $96.3 Million	-3,576,925 Reduced 96.46%	131,358 $2.71 Million
Q4 2023 Feb 14, 2024	SELL	$21.58 - $29.5 $3.77 Million - $5.16 Million	-174,880 Reduced 4.5%	3,708,283 $100 Million
Q3 2023 Nov 14, 2023	SELL	$25.8 - $39.97 $15 Million - $23.2 Million	-580,506 Reduced 13.01%	3,883,163 $115 Million
Q2 2023 Aug 15, 2023	BUY	$20.94 - $38.01 $24.3 Million - $44.2 Million	1,161,901 Added 35.19%	4,463,669 $160 Million
Q1 2023 May 15, 2023	BUY	$22.92 - $33.76 $18 Million - $26.5 Million	785,776 Added 31.23%	3,301,768 $77.4 Million
Q4 2022 Feb 14, 2023	BUY	$25.44 - $59.78 $45.4 Million - $107 Million	1,783,131 Added 243.31%	2,515,992 $68.4 Million
Q3 2022 Nov 15, 2022	SELL	$43.66 - $61.0 $6.01 Million - $8.4 Million	-137,658 Reduced 15.81%	732,861 $39.5 Million
Q2 2022 Aug 15, 2022	BUY	$28.82 - $77.35 $3.33 Million - $8.92 Million	115,383 Added 15.28%	870,519 $35.1 Million
Q1 2022 May 13, 2022	SELL	$48.25 - $100.49 $73,243 - $152,543	-1,518 Reduced 0.2%	755,136 $50 Million
Q4 2021 Feb 14, 2022	SELL	$88.71 - $120.43 $1.2 Million - $1.63 Million	-13,558 Reduced 1.76%	756,654 $75.7 Million
Q3 2021 Nov 10, 2021	SELL	$98.77 - $132.17 $3.48 Million - $4.66 Million	-35,243 Reduced 4.38%	770,212 $96.3 Million
Q2 2021 Jul 30, 2021	BUY	$109.77 - $165.68 $8.12 Million - $12.3 Million	73,943 Added 10.11%	805,455 $100 Million
Q1 2021 May 06, 2021	SELL	$127.04 - $179.1 $88.5 Million - $125 Million	-696,547 Reduced 48.78%	731,512 $112 Million
Q4 2020 Feb 08, 2021	SELL	$99.96 - $135.93 $4.06 Million - $5.53 Million	-40,658 Reduced 2.77%	1,428,059 $184 Million
Q3 2020 Nov 12, 2020	SELL	$80.32 - $111.8 $32.5 Million - $45.3 Million	-404,748 Reduced 21.6%	1,468,717 $164 Million
Q2 2020 Aug 13, 2020	BUY	$60.49 - $97.5 $14 Million - $22.6 Million	231,577 Added 14.1%	1,873,465 $152 Million
Q1 2020 May 14, 2020	BUY	$59.04 - $88.81 $1.02 Million - $1.53 Million	17,279 Added 1.06%	1,641,888 $114 Million
Q4 2019 Feb 18, 2020	BUY	$59.49 - $82.78 $19.7 Million - $27.4 Million	330,861 Added 25.57%	1,624,609 $127 Million
Q3 2019 Nov 14, 2019	BUY	$62.59 - $110.3 $11.4 Million - $20.2 Million	182,725 Added 16.45%	1,293,748 $82.6 Million
Q2 2019 Aug 14, 2019	BUY	$63.94 - $91.11 $31.8 Million - $45.3 Million	497,591 Added 81.12%	1,111,023 $95.9 Million
Q1 2019 May 14, 2019	SELL	$34.3 - $97.98 $7.95 Million - $22.7 Million	-231,643 Reduced 27.41%	613,432 $47.1 Million
Q4 2018 Feb 13, 2019	BUY	$29.2 - $46.1 $24.7 Million - $39 Million	845,075 New	845,075 $31.8 Million

Others Institutions Holding GH

# of Institutions

425

Shares Held

127M

Call Options Held

1.51M

Put Options Held

2.35M

View Full List

About Guardant Health, Inc.

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $9.51B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

More about GH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account

Alliancebernstein L.P. Guardant Health, Inc. Transaction History